Suven Life Sciences Limited — Quarter ended March 31, 2026 (audited standalone and consolidated; year ended March 31, 2026)
| Sl. No. | PARTICULARS | For the Quarter Ended | For the Year Ended | |||
|---|---|---|---|---|---|---|
| 31/03/2026 | 31/12/2025 | 31/03/2025 | 31/03/2026 | 31/03/2025 | ||
| Refer note.8 | Un-Audited | Refer note.8 | Audited | Audited | ||
| 1 | Income | |||||
| Revenue from operations | 152.01 | 280.87 | 146.70 | 711.47 | 665.58 | |
| Other Income | 677.78 | 276.59 | 119.08 | 1,391.05 | 1,072.59 | |
| Total income | 829.79 | 557.46 | 265.78 | 2,102.52 | 1,738.17 | |
| 2 | Expenses | |||||
| a) Cost of materials consumed | – | – | – | – | – | |
| b) Changes in inventories of finished goods, work-in-progress and stock-in-trade | – | – | – | – | – | |
| c) Employee benefits expense | 582.89 | 626.84 | 606.61 | 2,414.94 | 2,082.49 | |
| d) Finance costs | 15.78 | – | – | 15.78 | 4.66 | |
| e) Depreciation and amortisation expense | 158.25 | 134.58 | 134.67 | 561.35 | 582.17 | |
| f) R & D Expenses | 810.19 | 590.96 | 848.73 | 2,797.24 | 3,043.16 | |
| g) Other Expenses | 379.41 | 552.25 | 182.78 | 1,799.49 | 733.67 | |
| Total expenses | 1,946.52 | 1,904.63 | 1,772.79 | 7,588.80 | 6,446.15 | |
| 3 | Profit before exceptional items & Tax (1-2) | (1,116.73) | (1,347.17) | (1,507.01) | (5,486.28) | (4,707.98) |
| 4 | Exceptional Items | – | – | – | – | – |
| 5 | Profit before Tax (3-4) | (1,116.73) | (1,347.17) | (1,507.01) | (5,486.28) | (4,707.98) |
| 6 | Tax Expenses | |||||
| a) Current tax | – | – | – | – | – | |
| b) Deferred tax | – | – | – | – | – | |
| c) Tax of earlier years | – | – | – | – | – | |
| 7 | Net Profit/ (Loss) for the period/year (5-6) | (1,116.73) | (1,347.17) | (1,507.01) | (5,486.28) | (4,707.98) |
| 8 | Other Comprehensive Income | |||||
| 8.a | (i) Items that will not be reclassified to profit or loss | (22.45) | 3.26 | (4.64) | (22.19) | (5.99) |
| (ii) Income tax relating to items that will not be reclassified to profit or loss | – | – | – | – | – | |
| 8.b | (i) Items that will be reclassified to profit or loss | – | – | – | – | – |
| (ii) Income tax relating to items that will be reclassified to profit or loss | – | – | – | – | – | |
| Total other Comprehensive Income / (Loss) | (22.45) | 3.26 | (4.64) | (22.19) | (5.99) | |
| 9 | Total Comprehensive Income/ (Loss) for the period (5+6) | (1,139.18) | (1,343.91) | (1,511.65) | (5,508.47) | (4,713.97) |
| 10 | Paid-up equity share capital | 2,637.20 | 2,274.74 | 2,180.74 | 2,637.20 | 2,180.74 |
| Face Value of the Share | Re.1.00 | Re.1.00 | Re.1.00 | Re.1.00 | Re.1.00 | |
| 11 | Other Equity | – | – | – | 147,699.51 | 77,770.36 |
| 12 | Earning Per Share (EPS) (Face value of Rs.1/- each): | |||||
| a) Basic (Based on weighted average no. of shares) | (0.50) | (0.60) | (0.69) | (2.41) | (2.16) | |
| b) Diluted (Based on weighted average no. of shares) | (0.50) | (0.60) | (0.69) | (2.41) | (2.16) | |
| (not annualised) | (not annualised) | (not annualised) | (annualised) | (annualised) |
| Sl. No. | PARTICULARS | For the Quarter Ended | For the year ended |
|---|---|---|---|
| 31/03/2026 Refer note.8 | 31/12/2025 Un-Audited | ||
| 1 | Income | ||
| Revenue from operations | 152.01 | 280.87 | |
| Other Income | 677.78 | 277.45 | |
| Total income | 829.79 | 558.32 | |
| 2 | Expenses | ||
| a) Cost of materials consumed | – | – | |
| b) Changes in inventories of finished goods, work-in-progress and stock-in-trade | – | – | |
| c) Employee benefits expense | 582.89 | 626.84 | |
| d) Finance costs | 15.78 | – | |
| e) Depreciation and amortisation expense | 158.25 | 134.58 | |
| f) R & D Expenses | 4,233.12 | 9,404.72 | |
| g) Other Expenses | 399.30 | 584.36 | |
| Total expenses | 5,389.34 | 10,750.50 | |
| 3 | Profit before exceptional items & Tax (1-2) | (4,559.55) | (10,192.18) |
| 4 | Exceptional Items | – | – |
| 5 | Profit before Tax (3-4) | (4,559.55) | (10,192.18) |
| 4 | Tax Expenses | ||
| a) Current tax | – | – | |
| b) Deferred tax | – | – | |
| c) Tax of earlier years | – | – | |
| 5 | Net Profit/ (Loss) for the period/year (5-6) | (4,559.55) | (10,192.18) |
| 6 | Other Comprehensive Income | ||
| 6.a | (i) Items that will not be reclassified to profit or loss | (22.45) | |
| (ii) Income tax relating to items that will not be reclassified to profit or loss | – | – | |
| 6.b | (i) Items that will be reclassified to profit or loss | (24.21) | (78.39) |
| (ii) Income tax relating to items that will be reclassified to profit or loss | – | – | |
| Total other Comprehensive Income / (Loss) | (46.66) | (75.13) | |
| 7 | Total Comprehensive Income/ (Loss) for the period (5+6) | (4,606.21) | (10,267.31) |
| 8 | Paid-up equity share capital | 2,637.20 | 2,274.74 |
| Face Value of the Share | Re.1.00 | Re.1.00 | |
| 9 | Other Equity | – | – |
| 10 | Earning Per Share (EPS) (Face value of Rs.1/- each) : | ||
| a) Basic (Based on weighted average no. of shares) | (2.02) (not annualised) | (4.55) (not annualised) | |
| b) Diluted (Based on weighted average no. of shares) | (2.02) (not annualised) | (4.55) (not annualised) |
| Particulars | Standalone as at 31/03/2026 | Standalone as at 31/03/2025 | Consolidated as at 31/03/2026 | Consolidated as at 31/03/2025 |
|---|---|---|---|---|
| A. ASSETS | ||||
| 1. Non-current assets | ||||
| (a) Property, Plant and Equipment | 5,570.33 | 5,947.19 | 5,570.33 | 5,947.19 |
| (b) Capital Work-in-Progress | 359.60 | 0.97 | 359.60 | 0.97 |
| (c) Other Intangible Assets | 14.47 | 18.08 | 14.47 | 18.08 |
| (d) Right of use Assets | 1,714.74 | – | 1,714.74 | – |
| (e) Financial Assets | ||||
| I. Investments | 91,284.63 | 69,147.16 | – | – |
| II. Other financial assets | 87.50 | 4.86 | 87.50 | 4.86 |
| (f) Other Non-current Assets | 3.88 | – | 3.88 | – |
| Total Non-Current assets | 99,035.15 | 75,118.26 | 7,750.52 | 5,971.10 |
| 2. Current assets | ||||
| Inventories | 10.20 | 23.75 | 10.20 | 23.75 |
| (a) Financial Assets | ||||
| I. Investments in mutual funds | 18,065.16 | 2,227.85 | 18,065.16 | 2,227.85 |
| II. Trade Receivables | 150.84 | 133.64 | 150.84 | 133.64 |
| III. Cash and Cash equivalents | 228.13 | 46.35 | 827.91 | 1,502.55 |
| IV. Bank balances other than (III) above | 32,917.70 | 1,950.00 | 32,917.70 | 2,270.08 |
| V. Other financial assets | 370.31 | 7.60 | 370.31 | 7.60 |
| (b) Current Tax asset (net) | 194.92 | 119.00 | 194.92 | 119.00 |
| (c) Other current assets | 2,133.84 | 1,262.76 | 2,133.84 | 1,262.76 |
| Total Current assets | 54,071.10 | 5,770.95 | 54,670.88 | 7,547.23 |
| TOTAL – ASSETS | 153,106.25 | 80,889.21 | 62,421.40 | 13,518.33 |
| B. EQUITY AND LIABILITIES | ||||
| —————————————- | —————————- | —————————- | —————————— | —————————— |
| 1. EQUITY | ||||
| (a) Equity Share Capital | 2,637.21 | 2,180.74 | 2,637.21 | 2,180.74 |
| (b) Other Equity | 147,699.51 | 77 |